Skip to main content

Sofinnova Investments, Inc.

Position in REPL — Replimune Group, Inc.

CIK 1631134 Menlo Park, CA

Position in REPL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$16,782,654 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
10 quarters on record

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Mar 31, 2026
CallValue
$7,767,810
CallShares
1,015,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Sofinnova Investments, Inc. holds $1,140,503,369 across 48 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,767,810 1,015,400
2025-06-30 $16,782,654 1,806,529
2025-06-30 $13,935,000 1,500,000
2025-03-31 $24,179,405 2,479,939
2024-12-31 $38,140,711 3,149,522
2024-09-30 $527,592 48,138
2023-09-30 $8,620,770 503,844
2023-09-30 $5,357,141 313,100
2023-09-30 $4,277,500 250,000
2023-06-30 $8,101,202 348,889
2021-06-30 $2,753,215 71,661
2021-03-31 $4,338,796 142,209
2020-12-31 $763,000 20,000